FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

Invega Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Janssen Pharmaceuticals Invega (paliperidone) extended-release tablet was not withdrawn from sale due to ...

latest-news-card-1
Human Drugs

Janssens TB Drug Converted to Full Approval

FDA converts Janssens Sirturo (bedaquiline) from accelerated to traditional approval following a determination that a confirmatory trial verified clin...

latest-news-card-1
Human Drugs

Small Entity Compliance Guide on LDT Phase-out

FDA releases a guidance entitled Laboratory Developed Tests: Small Entity Compliance Guide.

Medical Devices

Endotronix Pulmonary Artery Sensor Approved

FDA approves an Endotronix PMA for its Cordella Pulmonary Artery Sensor System for treating New York Heart Failure Class III heart failure patients.

latest-news-card-1
Human Drugs

Committee Finds Troubling Foreign Inspection Issues

The House Energy and Commerce Committee seeks additional inspection records from FDA after its analysis of the foreign drug inspection program found t...

latest-news-card-1
Human Drugs

FDA Denies Petition Seeking Wakix Withdrawal

FDA denies a 4/2023 petition that called on the agency to withdraw approval for Harmony Biosciences Wakix (pitolisant) and take other actions against ...

latest-news-card-1
Federal Register

Switching Studies for Interchangeable Biosimilars Guide

Federal Register notice: FDA makes available a draft guidance entitled Considerations in Demonstrating Interchangeability With a Reference Product: Up...

latest-news-card-1
Federal Register

Guide on Adulteration when Inspection Refused

Federal Register notice: FDA makes available a final guidance entitled Circumstances That Constitute Delaying, Denying, Limiting, or Refusing a Drug o...

latest-news-card-1
Federal Register

Guide on Human User Safety in Animal Drugs

Federal Register notice: FDA makes available a final guidance entitled Human User Safety in New and Abbreviated New Animal Drug Applications.

latest-news-card-1
Human Drugs

Workshop on NDA/BLA Meeting Management Practices

FDA announces a 7/22 public workshop on Best Practices for Meeting Management Under PDUFA VII.